30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Paul Clancy

Track

Insider profile

Currently holds positions in Agios Pharmaceuticals Inc and Incyte Corp

Positions

Position Company Period
Independent Director Agios Pharmaceuticals Inc Sept. 24, 2013 -
Independent Director Incyte Corp Jan. 20, 2015 -
Chief Financial Officer, Executive Vice President Alexion Pharmaceuticals Inc July 31, 2017 - Sept. 17, 2019
Chief Financial Officer, Executive Vice President - Finance Biogen Inc Aug. 13, 2007 - June 30, 2017
Paul Clancy's trades of Incyte Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-21 2026-05-19
US Incyte Corp (INCY)
S Sale
71,569 -44.2%
119.41
US$4,336,826 		71,569 -44.2% 119.41 US$4,336,826
2026-05-21 2026-05-19
US Incyte Corp (INCY)
S Sale
39,611 -16.5%
364.80
US$1,074,681 		39,611 -16.5% 364.80 US$1,074,681
2026-05-19 2026-05-19
US Incyte Corp (INCY)
PrS Proposed sale
83,326
474.20
US$1,175,812 		83,326 474.20 US$1,175,812
2018-02-08 2018-02-08
S Sale
6,079 -6.4%
116.31
US$707,048 		6,079 -6.4% 116.31 US$707,048